Laparoscopic Gastric Bypass, Roux en-Y: Technique and Results in 75 Patients With 3-30 Months Follow-up

Wittgrove, Alan C.; Clark, G Wesley; Schubert, Katherine R

doi:10.1381/096089296765556412

Cited by 173 publications

(83 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…They have reported on their experience with 75 patients with 3 to 30 months of follow-up. 23 The operating time was 159 to 343 minutes. The mean hospital stay and recovery time were 2.8 days (range 2-75) and 15 days (range 7-30), respectively.…”

Section: Discussionmentioning

confidence: 99%

Outcomes After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity

et al. 2000

View full text Add to dashboard Cite

ObjectiveTo evaluate the short-term outcomes for laparoscopic Rouxen-Y gastric bypass in 275 patients with a follow-up of 1 to 31 months. Summary Background DataThe Roux-en-Y gastric bypass is a highly successful approach to morbid obesity but results in significant perioperative complications. A laparoscopic approach has significant potential to reduce perioperative complications and recovery time. MethodsConsecutive patients (n ϭ 275) who met NIH criteria for bariatric surgery were offered laparoscopic Roux-en-Y gastric bypass between July 1997 and March 2000. A 15-mL gastric pouch and a 75-cm Roux limb (150 cm for superobese) was created using five or six trocar incisions. ResultsThe conversion rate to open gastric bypass was 1%. The start of an oral diet began a mean of 1.58 days after surgery, with a median hospital stay of 2 days and return to work at 21 days. The incidence of early major and minor complications was 3.3% and 27%, respectively. One death occurred related to a pulmonary embolus (0.4%). The hernia rate was 0.7%, and wound infections requiring outpatient drainage only were uncommon (5%). Excess weight loss at 24 and 30 months was 83% and 77%, respectively. In patients with more than 1 year of follow-up, most of the comorbidities were improved or resolved, and 95% reported significant improvement in quality of life. ConclusionLaparoscopic Roux-en-Y gastric bypass is effective in achieving weight loss and in improving comorbidities and quality of life while reducing recovery time and perioperative complications.Roux-en-Y gastric bypass (RYGBP) has been shown to produce significant weight loss in patients with clinically severe obesity: most studies report a weight loss of 60% to 70% of excess body weight.

show abstract

Section: Discussionmentioning

confidence: 99%

Outcomes After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity

et al. 2000

View full text Add to dashboard Cite

show abstract

“…Patients typically reach maximum weight loss 1-2 years after surgery and maintain a substantial weight loss, with improvements in obesity-related conditions, for years afterwards o Patients may lose 30 to 50% of excess weight 6 months after surgery and 77% of excess weight as early as 12 months after surgery 17 …”

Section: Long-term Effectiveness Of Bariatric Surgerymentioning

confidence: 99%

Trimming the fat: obesity and hematopoietic cell transplantation

Weiss

Vogl

Berger

et al. 2012

Bone Marrow Transplant

View full text Add to dashboard Cite

“…It may be performed with several technical variables, such as the pouch capacity, the presence or not of a contention band in the pouch exit, the length of the alimentary and biliopancreatic loops, and the use of conventional or videolaparoscopic access (6,9,15,22,24) (Figures 1 and 2). …”

Section: Introductionmentioning

confidence: 99%

Early marginal ulcer following Roux-en-Y gastric bypass under proton pump inhibitor treatment: prospective multicentric study

Garrido¹,

Rossi²,

Lima³

et al. 2010

Arq. Gastroenterol.

View full text Add to dashboard Cite

-Context -Causal factors of gastrojejunal ulcers after Roux-en-Y gastric bypass include peptic acid secretion from the gastric pouch. Esomeprazole is a potent inhibitor of acid secretion. Objective -To assess the occurrence of dyspepsia and gastrojejunal ulcers within the first 2 months after Roux-en-Y gastric bypass during the use of esomeprazole. Methods -One hundred eighteen morbid obese subjects were submitted to Roux-en-Y gastric bypass. Preoperative upper gastrointestinal tract endoscopy was negative for H. pylori. All subjects received esomeprazole for 60 days after surgery. Results -Two weeks after surgery only 13 mild symptoms were reported. After 2 months, 17 also moderate complaints were registered. Endoscopy around the 60th day showed esophagitis in 10 (8.5%), hiatal hernia in 2 (1.7%), foreign body in the anastomotic line in 12 (10.2%) and gastrojejunal ulcers was observed in 9 (7.6%) subjects, 2 of which had a suture material or metallic staple granuloma in the gastrojejunostomy. Ten subjects took nonsteroidal anti-inflammatory drugs at least once during study, but none of them developed ulcer. None of the subjects with ulcer had dyspeptic symptoms. Conclusion -The incidence of ulcer in the gastrojejunal anastomosis within the first 2 months following Rouxen-Y gastric bypass under proton pump inhibitors is considerable. It was not related to the use of non-steroidal anti-inflammatory drugs, highlighting the possibility of ischemia and foreign body as causal factors. The ulcers were asymptomatic, and all post-surgical dyspeptic symptoms were moderate in severity.

show abstract

Laparoscopic Gastric Bypass, Roux en-Y: Technique and Results in 75 Patients With 3-30 Months Follow-up

Cited by 173 publications

References 8 publications

Outcomes After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity

Outcomes After Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity

Trimming the fat: obesity and hematopoietic cell transplantation

Early marginal ulcer following Roux-en-Y gastric bypass under proton pump inhibitor treatment: prospective multicentric study

Contact Info

Product

Resources

About